期刊文献+

miR-29c过表达载体的构建及其对95D肺癌细胞增殖的影响

Construction of miR-29c expression vector and its effect on proliferation of lung cancer 95D cells
下载PDF
导出
摘要 目的构建miR-29c真核表达载体并转染95D肺癌细胞,观察miR-29c过表达对95D细胞增殖能力的影响。方法克隆miR-29c片段插入质粒pcDNA3.1,构建miR-29c表达质粒pcDNA3.1-miR-29c;通过脂质体瞬时转染人肺癌细胞株95D,荧光PCR检测细胞miR-29c表达水平,MTT法检测过表达miR-29c对细胞增殖能力的影响。结果重组质粒pcDNA3.1-miR-29c经酶切及测序证明构建成功,荧光PCR证实转染后95D细胞miR-29c表达水平显著升高,是对照组的36倍。MTT检测结果表明,过表达miR-29c的95D细胞增殖受到显著抑制,至72 h抑制率最高,达38.63%。结论成功构建miR-29c真核表达质粒pcDNA3.1-miR-29c,初步观察显示过表达miR-29c显著抑制95D肺癌细胞增殖效应。为进一步深入研究miR-29c对肺癌的作用打下良好基础。 Objective To construct eukaryotic expression vector of miR-29c and to investigate its effect on proliferation of human lung cancer 95D ceils. Methods pcDNA3. 1-miR-29c was constructed by inserting cloned gene miR-29c to eukaryotic expression vector pcDNA3.1. Sequencing and restriction endonucleases were used to verify the recombinant vector. Human lung cancer 95D cells were transfected by pcDNA3. 1-miR-29c. The expression level of miR-29c in 95D cells after transfection was identified by Real-Time PCR. The cell proliferative levels were assessed by MTT test. Results The expression vector of recombined pcDNA3.1-miR-29c was successfully constructed. The miR-29c expression levels in 95D cells after transfection significantly increased and were 36 times as that of control group. The proliferative activity was suppressed in pcDNA3. 1-miR-29c cells and the inhibition rate reached the highest 38.63% at 72 hour. Conclusion MiR-29c eukaryotic expression plasmid pcDNA3. 1-miR-29c was successfully constructed. Preliminary study indicated that over- expression of miR-29c can inhibit the proliferation of human lung cancer 95D cells.
出处 《同济大学学报(医学版)》 CAS 2013年第4期6-9,共4页 Journal of Tongji University(Medical Science)
基金 国家自然科学青年基金(30800631)
关键词 miR-29c 肺肿瘤 95D细胞 细胞增殖 miR-29c lung cancer 95D cell cell proliferation
  • 相关文献

参考文献9

  • 1Wang G,Zhang H, He H, et al. Up-regulation ofmicroRNA in bladder tumor tissue is not common[ J].Int Urol Nephrol, 2010,42: 95 -102.
  • 2Castilla MA, Moreno-Bueno G, Romero PL, et al.microRNA signature of the epithelial-mesenchymaltransition in endometrial carcinosarconia[ J] . J Pathol,2011,223: 72-80.
  • 3Xiong Y, Fang JH, Yun JP, et al. Effects ofMicroRNA-29 on apoptosis, tumorigenicity and pro-gnosis of hepatocellular carcinoma [ J ]. Hepatology.2009,51(3) : 836-845.
  • 4Nguyen T,Kuo C,Nicholl MB, et al. Down-regulation of microRNA-29c is associated with hypermethylation of tumor-related genes and disease outcomein cutaneous melanoma [ J ]. Epigenetics, 2011, 6:388 -394.
  • 5Zhang H,Li Y, Lai M. The microRNA network andtumor metastasis [ J ]. Oncogene, 2010,29 ( 7 ):937 -948.
  • 6Cho WC. OncomiRs : the discovery and progress ofmicroRNAs in cancers [ J ]. Mol Cancer, 2007,6 : 60.
  • 7Krutzfeldt J, Poy MN, Stoffel M. Strategies todetermine the biological function of microRNAs [ J ].Nat Genet, 2006,38(Suppl) : S14 — S19.
  • 8Plaisier CL, Pan M, Baliga NS. A miRNA-reguIatorynetwork explains how dysregulated miRNAs perturboncogenic processes across diverse cancers [ J ].Genome Res, 2012,22( 11) : 2302 -2314.
  • 9Wang CM, Wang Y,Fan CG’ et al. miR-29c targetsTNFAIP3, inhibits cell proliferation and inducesapoptosis in hepatitis B virus-related hepatocellularcarcinoma[ J]. Biochem Biophys Res Commun, 2011,411(3) : 586-592.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部